Patents by Inventor Paul Actor

Paul Actor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Retroinverso polypeptides that mimic or inhibit thrombospondin
    Publication number: 20030171298
    Abstract: The present invention relates generally to polypeptides that mimic or inhibit the biological activity of thrombospondin, and particularly to polypeptides in retroinverso form. The peptides. These polypeptides may be used biological and pharmaceutical applications such as: (a) inhibiting the invasive and metastatic activity of melanoma cells, (b) promoting and inhibiting cellular attachment to tissue culture flasks, (c) promoting wound healing, angiogenesis, and implant acceptance, (d) agents for anti-platelet aggregation, (e) agents for antimalarial activity, and (f) diagnostic reagents in different therapeutic applications, as well as other related areas.
    Type: Application
    Filed: October 3, 2001
    Publication date: September 11, 2003
    Applicant: INKINE PHARMACEUTICALS MCP HAHNEMANN
    Inventors: Taffy Williams, George Tuszynski, Paul Actor
  • Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions
    Patent number: 6380161
    Abstract: The present invention provides methods and compositions for treating cancer and chemotherapy-resistant cancers comprising a chemotherapeutic agent conjugated to or coadministered with a peptide.
    Type: Grant
    Filed: June 20, 2000
    Date of Patent: April 30, 2002
    Assignees: Inkine Pharmaceutical Company, Inc., Philadelphia Health and Education Corporation
    Inventors: Taffy Williams, George Tuszynski, Paul Actor
  • Retroinverso polypeptides that mimic or inhibit thrombospondin activity
    Patent number: 6339062
    Abstract: The present invention relates generally to polypeptides that mimic or inhibit the biological activity of thrombospondin, and particularly to polypeptides in retroinverso form. These polypeptides may be used for their biological and pharmaceutical applications such as: (a) inhibiting the invasive and metastatic activity of melanoma cells, (b) promoting and inhibiting cellular attachment to tissue culture flacks, (c) promoting wound healing, angiogenesis, and implant acceptance, (d) agents for anti-platelet aggregation, (e) agents for antimalarial activity, and (f) diagnostic reagents in different therapeutic applications, as well as other related areas.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: January 15, 2002
    Assignee: Inkine Pharmaceutical Company, Inc.
    Inventors: Taffy Williams, George Tuszynski, Paul Actor